Mark J. Whalen
Plus aucun poste en cours
Profil
Mr. Mark J.
Whalen is Vice President-Research & Development at AbbeyMoor Medical, Inc.
Mr. Whalen was previously employed as Senior Engineer-Product Development by Scimed Life Systems, Inc. Minnesota.
He received his undergraduate degree from North Dakota State University.
Anciens postes connus de Mark J. Whalen
| Sociétés | Poste | Fin |
|---|---|---|
SCIMED Life Systems, Inc. (Minnesota)
 SCIMED Life Systems, Inc. (Minnesota) Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., SCIMED Life Systems, Inc. is a company that specializes in artery cleaning angioplasty catheters. The company is based in Osseo, MN. The company was founded by Lawrence L. Horsch. SCIMED Life Systems, Inc. (Minnesota) was acquired by Boston Scientific Corp. on February 27, 1995 for $865 million. | Corporate Officer/Principal | - |
AbbeyMoor Medical, Inc.
 AbbeyMoor Medical, Inc. Medical SpecialtiesHealth Technology AbbeyMoor Medical, Inc. develops intraurethral medical devices for the management of male urinary voiding dysfunction. The company was founded in 1996 and is headquartered in Alexandria, MN. | Directeur Technique/Scientifique/R&D | - |
Formation de Mark J. Whalen
| North Dakota State University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
AbbeyMoor Medical, Inc.
AbbeyMoor Medical, Inc. Medical SpecialtiesHealth Technology AbbeyMoor Medical, Inc. develops intraurethral medical devices for the management of male urinary voiding dysfunction. The company was founded in 1996 and is headquartered in Alexandria, MN. | Health Technology |
SCIMED Life Systems, Inc. (Minnesota)
SCIMED Life Systems, Inc. (Minnesota) Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., SCIMED Life Systems, Inc. is a company that specializes in artery cleaning angioplasty catheters. The company is based in Osseo, MN. The company was founded by Lawrence L. Horsch. SCIMED Life Systems, Inc. (Minnesota) was acquired by Boston Scientific Corp. on February 27, 1995 for $865 million. | Health Technology |
